Table S8 from Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2− Breast Cancer

Key Points

• HR+/HER2− breast cancer treatment improves with subtyping-directed precision therapy, indicating personalized strategies.
• Precision treatment criteria for matched and unmatched groups enhance therapy outcomes in breast cancer patients.
• This approach involves subtyping methods to determine optimal treatment pathways for better patient outcomes.
• The findings may support shifts away from traditional one-size-fits-all therapy to more tailored interventions.